Iterum Therapeutics

$1.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.11 (-6.29%) Today

+$0.06 (+3.66%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ITRM and other stocks, options, and ETFs commission-free!

About ITRM

Iterum Therapeutics plc Ordinary Share, also called Iterum Therapeutics, is a pharmaceutical company, which engages in the development and commercialization of sulopenem to be potentially the first and only oral and intravenous (IV) branded penem available. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland. The listed name for ITRM is Iterum Therapeutics plc Ordinary Share.

CEO

Corey N. Fishman

Employees

Headquarters

Dublin, Dublin

Founded

2015

Market Cap

268.70M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

31.49M

High Today

$1.75

Low Today

$1.55

Open Price

$1.71

Volume

15.23M

52 Week High

$6.02

52 Week Low

$0.451

ITRM Earnings

-$2.15

-$1.43

-$0.72

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 11, Pre-Market